About
Solutions
Pipeline
Publications
News
Careers
Contact Us

News

Loading...

Our Mission
Hard-to-Drug Targets
Our Journey
Selected Partners
Investors

Proprietary AI Platforms
Honors
Innovations
Technology Partners and Providers

Wholly Owned
Design as a Service
Co-developed

In the News
Press Releases

Nature
Cell Press
PubMed

London
Shanghai
Hangzhou

Copyright © 2026 MindRank Ltd. All Rights Reserved.

Track Our News on

2021-08-05

MindRank AI and HaoYuan Chemexpress (SHA: 688131) Establish Strategic Colleboration to Develop AI-assisted Chemical Synthesis Platform

2021-06-10

MindRank AI Win the Championship in the Global Artificial Intelligence Technology Innovation Contest

2021-05-24

MindRank AI completed tens of millions of angel round financing, Sherpa Medical Fund led the investment

6 / 6

6 / 6